Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radical radiotherapy with or without gemcitabine for early-stage unresectable non-small cell lung cancer
ISRCTN61727489Phase 3Completed
- Sponsor
- University of Edinburgh
- Start
- Jan 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of gemcitabine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by University of Edinburgh. Started Jan 2003; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ISRCTN61727489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN61727489.